Citadel Advisors
SZYM

Citadel Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Citadel Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-47,587
Closed -$97K – 7907
2016
Q1 		$97K Buy
+47,587
New +$84.9K ﹤0.01% 6044
2015
Q3 		– Sell
-9,369
Closed -$24.4K – 9538
2015
Q2 		$29K Sell
9,369
-10,243
-52% -$35.1K ﹤0.01% 7990
2015
Q1 		$56K Sell
19,612
-2,933
-13% -$7.5K ﹤0.01% 7315
2014
Q4 		$58K Sell
22,545
-41,303
-65% -$181K ﹤0.01% 7092
2014
Q3 		$476K Buy
63,848
+6,253
+11% +$58.4K ﹤0.01% 4688
2014
Q2 		$678K Buy
57,595
+31,242
+119% +$333K ﹤0.01% 3983
2014
Q1 		$306K Buy
26,353
+16,238
+161% +$191K ﹤0.01% 4996
2013
Q4 		$110K Sell
10,115
-16,069
-61% -$158K ﹤0.01% 5540
2013
Q3 		$282K Buy
26,184
+21,808
+498% +$248K ﹤0.01% 4425
2013
Q2 		$51K Buy
+4,376
New +$43.7K ﹤0.01% 5660

Citadel Advisors's SZYM Position: Q2 2016 in Review

Citadel Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 47,587 shares — an estimated $97K sold.

Citadel Advisors first reported a position in SZYM in Q2 2013 and held it in 10 quarters. The position peaked at $678K in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Citadel Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Citadel Advisors sold 47,587 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $97K.
  • Citadel Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 10 quarters.
  • Citadel Advisors's SOLAZYME INC COM STK (DE) position peaked at $678K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.